A new study conducted by scientists at the University of Texas Medical Branch suggests that the antiviral drug obeldesivir may be effective in treating Ebola Sudan infections, for which there are currently no approved vaccines or treatments. The drug, given in pill form, showed promising results in primate tests, with all treated animals surviving. If proven effective in humans, obeldesivir could be a game-changer in controlling Ebola outbreaks. The drug’s ability to be stored at room temperature, its relative affordability, and potential for treating multiple filoviruses make it a promising candidate for further research and development.
Source link
Gilead Sciences antiviral shows promise as new treatment
